Prosecution Insights
Last updated: November 20, 2026
Application No. 18/647,671

OVERLAPPING DATA STREAMS AND SENSOR TRANSITIONS

Non-Final OA §101§102§103§112
Filed
Apr 26, 2024
Priority
Apr 28, 2023 — provisional 63/499,121
Examiner
CATINA, MICHAEL ANTHONY
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
DexCom Inc.
OA Round
1 (Non-Final)
32%
Grant Probability
At Risk
1-2
OA Rounds
2y 1m
Est. Remaining
62%
With Interview

Examiner Intelligence

Grants only 32% of cases
32%
Career Allowance Rate
173 granted / 548 resolved
-38.4% vs TC avg
Strong +31% interview lift
Without
With
+30.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 8m
Avg Prosecution
45 currently pending
Career history
614
Total Applications
across all art units

Statute-Specific Performance

§101
20.6%
-19.4% vs TC avg
§103
39.4%
-0.6% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
27.5%
-12.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 548 resolved cases

Office Action

§101 §102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of claims 1-13 and 19-22 in the reply filed on 7/22/26 is acknowledged. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-13 and 19-22 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim recites the steps of receiving a first and second data stream and generating a combined analyte measurement based on a received first analyte measurement and a received second analyte measurement. The limitation of generating a combined analyte measurement based on a received first analyte measurement and a received second analyte measurement, as drafted, is a process that, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components. That is, other than reciting “a computing device” and first and second analyte monitoring device, the claims are direct to concepts relating to organizing information in a way that can be performed mentally or analogous to human mental work and nothing in the claim element precludes the steps from practically being performed in the mind. For example, but for the processor, communications interface and output language, “generating” in the context of this claim encompasses the user manually calculating combined data points. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components, then it falls within the “Mental Processes” grouping of abstract ideas. Accordingly, the claim recites an abstract idea. This judicial exception is not integrated into a practical application. In particular, the claim recites the additional elements of obtaining first and second digital data from the first and second analyte detectors. These analyte monitoring devices involve mere data gathering and amount to insignificant extra-solutional activity, specifically pre-solutional activity. Additionally, computing device is recited at a high-level of generality such that it amounts no more than mere instructions to apply the exception using generic computer components. Accordingly, these additional elements do not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea. The claim is directed to an abstract idea. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception. Similarly, the dependent claims do not include additional elements that amount to significantly more. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept and well-understood, routine and conventional activity is not sufficient to amount to significantly more than the abstract idea itself. The claim is not patent eligible. Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claims 19-22 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Part of the claimed system is an analyte sensor worn by the patient which encompasses the human body. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The claim recites that the second analyte measurements contribute more at the end of the period than at the end of the period. It is presumed that this was meant to be the opposite of claim 7 and say the second analyte measurement is weight more towards the end of the overlap period than at the beginning of the overlap period. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 2, 5, 6, 19, 21 and 22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kamath et al. US 2012/0277566. Regarding claim 1, 19 and 21, Kamath discloses a method, comprising: receiving, at a computing device and during an overlap period, a first data stream of first analyte measurements from a first analyte sensor worn by a user ([FIG.21][¶417-424] the device receives data from a first continuous analyte sensor); receiving, at the computing device and during the overlap period, a second data stream of second analyte measurements from a second analyte sensor worn by the user, the first data stream and the second data stream received concurrently during the overlap period ([FIG.21][¶417-424] the device also receives data from a reference analyte sensor during the same time period and the reference sensor can be another continuous analyte sensor like in FIG. 1); generating a combined analyte measurement based on the first analyte measurements and the second analyte measurements ([FIG.21][¶419-425,452-454] the two sensor data streams are used to determine a calibration function to determine blood glucose concentrations); and outputting, on a display of the computing device, the combined analyte measurement ([¶452-454] the determinations are displayed). Regarding claim 2 and 22, Kamath discloses generating the combined analyte measurement comprises: applying a first weight to the first analyte measurements received from the first analyte sensor; applying a second weight to the second analyte measurements received from the second analyte sensor ([¶419] the two data analyte measurements can be weighted); and generating the combined analyte measurement based on the weighted first analyte measurements and the weighted second analyte measurements ([FIG.21][¶419-425,452-454] the two sensor data streams are used to determine a calibration function to determine blood glucose concentrations). Regarding claim 5, Kamath discloses generating the combined analyte measurement comprises determining a sum of the weighted first analyte measurements and the weighted second analyte measurements ([¶419] a weighted average can be used which is summing the measurements and dividing). Regarding claim 6, Kamath discloses the generating the combined analyte measurement comprises generating a weighted average of the first analyte measurements and the second analyte measurements ([¶419] weighted average). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 3-4 and 7-8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kamath et al. US 2012/0277566. Regarding claim 3, Kamath discloses the first weight is relatively larger towards a beginning of the overlap period and relatively smaller towards an end of the overlap period ([¶138] the second sensor or newer sensor requires a stabilization period so it would have been obvious to one of ordinary skill to rely more heavily on the sensors readings of the first sensor that has established stability). Regarding claim 4, Kamath discloses the second weight is relatively smaller towards a beginning of the overlap period and relatively larger towards an end of the overlap period ([¶138] the second sensor or newer sensor requires a stabilization period so it would have been obvious to one of ordinary skill to rely more heavily on the sensors readings of the first sensor that has established stability). Regarding claim 7, Kamath discloses the first analyte measurements contribute more towards the combined analyte measurement towards a beginning of an overlap period than at an end of the overlap period ([¶138] the second sensor or newer sensor requires a stabilization period so it would have been obvious to one of ordinary skill to rely more heavily on the sensors readings of the first sensor that has established stability). Regarding claim 8, Kamath discloses the second analyte measurements contribute more towards the combined analyte measurement towards an end of an overlap period than at an end of the overlap period ([¶138] the second sensor or newer sensor requires a stabilization period so it would have been obvious to one of ordinary skill to rely more heavily on the sensors readings of the first sensor that has established stability). Claim(s) 9-11 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kamath et al. US 2012/0277566 further in view of Cosentino et al. US 2015/0106124. Regarding claim 9, Kamath does not specifically disclose the generating the combined analyte measurement further comprises: determining which of the first analyte measurements and the second analyte measurements are more accurate; and outputting the more accurate analyte measurements. Cosentino teaches a similar glucose monitoring device that determines accuracy of the received signals and displays based on the determination of high and low accuracy ([¶43-45] the system determines a level of accuracy and then either displays only more accurate readings or readings can be displayed with their accuracy level). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the device of Kamath with the accuracy determinations of Cosentino in order to improve calculations and further processing ([¶55-57]). Regarding claim 10, Cosentino teaches the less accurate analyte measurements are not output ([¶43-45,55-57]). Regarding claim 11, Cosentino teaches the less accurate analyte measurements are output concurrently with the more accurate analyte measurements, and wherein the less accurate analyte measurements include an indication that they are less accurate ([¶43-45,55-57] the accuracy levels can be shown with the data or the readings are sorted based on their accuracy groupings). Claim(s) 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kamath et al. US 2012/0277566 further in view of Belliveau et al. US 2018/0182491. Regarding claim 20, Kamath discloses overlapping the sensors ([¶147] apply a second sensor and remove a first sensor) but does not specify that it provides instructions. Belliveau teaches the overlap system is further configured to :prior to the overlap period, output a notification on the display of the computing device instructing the user to apply the second analyte monitoring device; and during the overlap period, output a second notification on the display of the computing device instructing the user to remove the first analyte monitoring device ([¶245] the system can provide instructions for removal). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the device of Kamath with the instructions of Belliveau in order to allow the user to change the sensors without needing a health care provider ([¶429]). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL ANTHONY CATINA whose telephone number is (571)270-5951. The examiner can normally be reached 10-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Chen can be reached at 5712723672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL A CATINA/Examiner, Art Unit 3791 /TSE CHEN/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Apr 26, 2024
Application Filed
Oct 23, 2026
Non-Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733842
SYSTEM AND METHOD FOR MODE SWITCHING
10y 6m to grant Granted Sep 15, 2026
Patent 12648716
SYSTEM AND METHOD FOR MODE SWITCHING
6y 1m to grant Granted Jun 09, 2026
Patent 12629072
Method And System For Determining The Intention Of Performing A Voluntary Action
3y 10m to grant Granted May 19, 2026
Patent 12611127
DIAGNOSIS DEVICE USING SALIVA AND DIAGNOSIS METHOD USING THE SAME
8y 0m to grant Granted Apr 28, 2026
Patent 12599304
CONFIGURABLE HARDWARE PLATFORM FOR PHYSIOLOGICAL MONITORING OF A LIVING BODY
2y 9m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
32%
Grant Probability
62%
With Interview (+30.9%)
4y 8m (~2y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 548 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month